oxymatrine has been researched along with cardiovascular agents in 2 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, D; Jiangbo, Y; Runtao, G; Shusen, Y; Xu, W | 1 |
| Dong, Z; Fu, J; Gong, Y; Jin, L; Li, B; Sun, M; Yang, B; Zhang, K; Zhang, Y; Zhao, X | 1 |
2 other study(ies) available for oxymatrine and cardiovascular agents
| Article | Year |
|---|---|
Oxymatrine, the main alkaloid component of Sophora roots, protects heart against arrhythmias in rats.
Topics: Aconitine; Alkaloids; Animals; Arrhythmias, Cardiac; Calcium; Cardiovascular Agents; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Myocytes, Cardiac; Phytotherapy; Plant Extracts; Plant Roots; Quinolizines; Rats; Rats, Wistar; Sodium; Sodium Channels; Sophora | 2011 |
Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.
Topics: Action Potentials; Alkaloids; Animals; Arsenic Trioxide; Arsenicals; Cardiovascular Agents; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; In Vitro Techniques; Matrines; Myocytes, Cardiac; Oxides; Patch-Clamp Techniques; Promoter Regions, Genetic; Quinolizines; Sp1 Transcription Factor; Up-Regulation | 2013 |